Peptic ulcer disease (PUD) is a common cause of acute upper gastrointestinal (GI) bleeding with a significant impact on healthcare costs in the United States.1 Helicobacter pylori is a main risk factor for PUD, with high rates of rebleeding (27% to 81%) that have been shown to be reduced to less than 5% with eradication therapy.2 Guidelines recommend that all patients with PUD be tested for H pylori and if positive undergo treatment and subsequent testing to confirm eradication.3 In a recent study by Hung et al, 81% of inpatients presenting with upper GI bleeding due to PUD were tested for H pylori, an improvement from <60% historically, but still disappointingly low.